United Therapeutics | UTHR - Equity Capital And Reserves

Stock Price
534.34
Daily Change
-1.78 -0.33%
Monthly
10.76%
Yearly
65.46%
Q1 Forecast
519.93

United Therapeutics reported $7.1B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Amarin USD 458.89M 6.03M Sep/2025
Ardelyx USD 154.28M 14.75M Sep/2025
Baxter International USD 6.13B 1.11B Dec/2025
Bayer EUR 25.95B 3.75B Dec/2025
BioCryst Pharmaceuticals USD -119.15M 268.74M Dec/2025
Biogen USD 18.21B 573.5M Sep/2025
BioMarin Pharmaceutical USD 6.09B 30.29M Dec/2025
Emergent BioSolutions USD 649.3M 47.9M Dec/2023
Esperion Therapeutics USD -301.96M 149.4M Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Halozyme Therapeutics USD 48.81M 455.1M Dec/2025
Insmed USD 738.98M 206.6M Dec/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
J&J USD 78.47B 0 Sep/2025
Lexicon Pharmaceuticals USD 107.54M 12.62M Dec/2025
Moderna USD 8.65B 680M Dec/2025
Omeros USD -228.68M 15.13M Jun/2025
Pfizer USD 92.8B 4.11B Sep/2025
PTC Therapeutics USD -205.31M 49.56M Dec/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
Sarepta Therapeutics USD 1.14B 179.5M Dec/2025
Teva Pharmaceutical Industries USD 7.91B 664M Dec/2025
United Therapeutics USD 7.1B 506M Dec/2025
Vertex Pharmaceuticals USD 18.67B 1.35B Dec/2025